Omicron BA.2 less severe than its original and Delta variants : Study

The Omicron BA.2 subvariant is less severe than the Delta variant and to an even greater extent than the original Omicron variant, according to the US-based Massachusetts General Hospital

Covid test
Photo: Bloomberg
Press Trust of India Washington
3 min read Last Updated : Oct 27 2022 | 7:17 PM IST

The Omicron BA.2 subvariant is less severe than the Delta variant and to an even greater extent than the original Omicron variant, according to a research team led by investigators at the US-based Massachusetts General Hospital.

Of 1,02,315 confirmed COVID-19 cases in the US from March 3, 2020 to June 20 this year, there were 20,770 labelled as Delta variants, 52,605 labelled as Omicron B.1.1.529 variants, the original Omicron variant, and 28,940 labelled as Omicron BA.2 subvariants, researchers found.

Mortality rates were 0.7 per cent for Delta, 0.4 per cent for the original Omicron variant and 0.3 per cent for Omicron BA.2.

The researchers said after adjustments, the odds of death were more than two times higher for the Delta and the original Omicron variant compared with Omicron BA.2.

Patients with Delta and original Omicron variants were also more likely to need hospitalisation, invasive ventilation and intensive care admissions, according to the study, which has been published in the Journal of the American Medical Association (JAMA) Network Open.

These findings suggest that the severity of SARS-Cov-2 may be diminishing, according to the study.

To provide an accurate assessment of the severity of SARS-Cov-2 variants above and beyond previous studies, the researchers used a method called entropy balancing to account for potential confounding factors such as prior infections, vaccinations, treatments and comorbidities.

The team applied this method to data leveraged from the Mass General Brigham's electronic health record system that is linked to a COVID-19 vaccine registry, the researchers said.

"While the SARS-CoV-2 virus always has the potential to mutate to a more deadly form, when you look at the recent trajectory of Delta, Omicron BA.1, to Omicron BA.2, the virus seems to be getting intrinsically less severe. Hopefully this trend will continue," the study's lead author, Zachary Strasser, said.

"We can continue to use our analytics system and method to assess many other questions such as which vaccinations have the most impact on preventing long Covid, or whether certain treatments reduce the likelihood of long Covid," Strasser said.

The Omicron variant of concern was the dominant one earlier in the year, circulating globally and accounting for nearly all sequences reported to GISAID, an initiative which promotes rapid sharing of data from all influenza viruses and the coronavirus causing COVID-19.

Omicron is made up of several sublineages, the most common ones reported at that time being BA.1, BA.1.1 and BA.2.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsUSA

First Published: Oct 27 2022 | 7:17 PM IST

Next Story